Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant

Background: Mammalian target of rapamycin (mTOR) inhibitors, such as everolimus and sirolimus, may be efficacious in preserving renal function in liver transplantation (LT) recipients while preventing hepatocellular carcinoma (HCC) recurrence. Materials and Methods: In this study, we retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Pil Soo, Han, Ji Won, Seo, Changho, Ahn, Joseph, Lee, Soon Kyu, Nam, Hee Chul, Choi, Ho Joong, You, Young Kyoung, Jang, Jeong Won, Choi, Jong Young, Yoon, Seung Kew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314303/
https://www.ncbi.nlm.nih.gov/pubmed/34326770
http://dx.doi.org/10.3389/fphar.2021.685176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314303/
https://www.ncbi.nlm.nih.gov/pubmed/34326770
http://dx.doi.org/10.3389/fphar.2021.685176

Ejemplares similares